PURPOSE: We sought to determine efficacy, safety, and outcome of stereotactic
hypofractionated radiation therapy (SHORT) as a suitable bridging therapy for patients …

Introduction. This study evaluated long-term outcomes of salvage surgery as additional
therapy following downstaging of hepatocellular carcinoma (HCC) with transarterial …

Abstract Background & Aims The French alpha‐fetoprotein (AFP) model has recently shown
superior results compared to Milan criteria (MC) for prediction of hepatocellular carcinoma …

As the number of effective treatment options has increased, the management of patients with
hepatocellular carcinoma has become complex. The most appropriate therapy depends …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, and its
increasing incidence worldwide is a cause for concern. Fortunately, advances in diagnostic …

Importance Serum α-fetoprotein (AFP) is a biomarker for hepatocellular carcinomas (HCCs)
associated with a more aggressive tumor phenotype and inferior outcomes after a liver …

Purpose Percutaneous laser ablation (PLA) has been proposed as an active treatment in
patients with hepatocellular carcinoma (HCC). However, large multicenter studies using this …

Hepatocellular carcinoma (HCC) presents significant treatment challenges despite
considerable advancements in its management. The Indian National Association for the …

Background & Aims Liver transplant priority in the US and Europe follows the 'sickest-
first'principle. However, for patients with hepatocellular carcinoma (HCC), priority is based …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …